Top Markets
#1 Official Trump Official Trump +39.89%
#2 Melania Meme Melania Meme +20.05%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.56%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +17.46%
#6 Wrapped POL Wrapped POL +16.68%
#7 POL (ex-MATIC) POL (ex-MATIC) +16.52%
#8 Mubarak Mubarak +15.50%
#9 Unit Pump Unit Pump +10.98%
#10 Pump.fun Pump.fun +10.98%
Coin of the day
Official Trump Official Trump
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classifica tra le azioni #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Prezzo delle azioni
$0.17616661
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$73.48M
Variazione (1 giorno)
0.18%
Variazione (1 anno)
-37.76%
Paese
TW
Scambia Mercury Biopharmaceutical Corporation (6932)

Categoria

Healthcare
EPS per Mercury Biopharmaceutical Corporation (6932)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Mercury Biopharmaceutical Corporation, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Mercury Biopharmaceutical Corporation da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $0.56 -
IN